DK2025750T3 - Targets og forbindelser til terapeutisk intervention af HIV-infektion - Google Patents

Targets og forbindelser til terapeutisk intervention af HIV-infektion

Info

Publication number
DK2025750T3
DK2025750T3 DK07015899.3T DK07015899T DK2025750T3 DK 2025750 T3 DK2025750 T3 DK 2025750T3 DK 07015899 T DK07015899 T DK 07015899T DK 2025750 T3 DK2025750 T3 DK 2025750T3
Authority
DK
Denmark
Prior art keywords
targets
therapeutic intervention
compounds
hiv infection
intervention
Prior art date
Application number
DK07015899.3T
Other languages
English (en)
Inventor
Claudia Dr Carl
Annette Dr Friebe
Hanjo Dr Hennemann
Nina Schuermann
Sabine Wirths
Original Assignee
Nexigen Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexigen Gmbh filed Critical Nexigen Gmbh
Application granted granted Critical
Publication of DK2025750T3 publication Critical patent/DK2025750T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK07015899.3T 2007-08-13 2007-08-13 Targets og forbindelser til terapeutisk intervention af HIV-infektion DK2025750T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07015899A EP2025750B1 (en) 2007-08-13 2007-08-13 Targets and compounds for therapeutic intervention of HIV infection

Publications (1)

Publication Number Publication Date
DK2025750T3 true DK2025750T3 (da) 2012-02-20

Family

ID=38984065

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07015899.3T DK2025750T3 (da) 2007-08-13 2007-08-13 Targets og forbindelser til terapeutisk intervention af HIV-infektion

Country Status (9)

Country Link
US (1) US8685652B2 (da)
EP (2) EP2025750B1 (da)
JP (1) JP2010535846A (da)
AT (1) ATE539155T1 (da)
CA (1) CA2700923A1 (da)
DK (1) DK2025750T3 (da)
ES (1) ES2378852T3 (da)
IL (1) IL203873A0 (da)
WO (1) WO2009021971A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2550532A4 (en) * 2010-03-22 2013-11-20 Einstein Coll Med METHOD FOR THE SUPPRESSION OF TUMORS, INCREASED WEIGHT LOSS AND / OR INCREASED INSULIN SENSITIVITY
CN102516370A (zh) * 2011-12-16 2012-06-27 吉林大学第一医院 抗hiv的药物靶点及其在制药中的用途
US9738643B2 (en) 2012-08-06 2017-08-22 Duke University Substituted indazoles for targeting Hsp90
WO2015106003A1 (en) * 2014-01-08 2015-07-16 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Ras pathways as markers of protection against hiv and methods to improve vaccine efficacy
WO2017184956A1 (en) 2016-04-22 2017-10-26 Duke University Compounds and methods for targeting hsp90
CN108588081A (zh) * 2018-02-01 2018-09-28 上海市东方医院 一种靶向细胞核的序列及其应用
WO2024102988A1 (en) * 2022-11-11 2024-05-16 Mayo Foundation For Medical Education And Research Treating proteinopathies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004012406T2 (de) 2003-05-23 2009-04-30 Oregon Health & Science University, Portland Verfahren zur identifikation von inhibitoren
ATE506456T1 (de) * 2003-06-10 2011-05-15 David Gladstone Inst Verfahren zur behandlung von lentivirusinfektionen
WO2005023985A2 (en) 2003-09-03 2005-03-17 University Of Rochester Cytidine deaminase activators, deoxycytidine deaminase activators, vif antagonists, and methods of screening for molecules thereof
KR20080059634A (ko) 2005-10-06 2008-06-30 유니버시티 오브 매사추세츠 Ｈｉｖ 복제를 억제하기 위한 시약의 조성물 및 합성법

Also Published As

Publication number Publication date
JP2010535846A (ja) 2010-11-25
WO2009021971A2 (en) 2009-02-19
WO2009021971A3 (en) 2009-04-02
EP2185703A2 (en) 2010-05-19
EP2025750B1 (en) 2011-12-28
US20110065198A1 (en) 2011-03-17
CA2700923A1 (en) 2009-02-19
EP2025750A1 (en) 2009-02-18
US8685652B2 (en) 2014-04-01
IL203873A0 (en) 2011-07-31
ES2378852T3 (es) 2012-04-18
ATE539155T1 (de) 2012-01-15

Similar Documents

Publication Publication Date Title
DK1716162T3 (da) Phosphonater, amidomonophosphonater, amidobisphosphonater til behandling af virussygdomme
DK1773999T3 (da) Vaccine til forebyggelse og behandling af HIV-infektion
DK2025750T3 (da) Targets og forbindelser til terapeutisk intervention af HIV-infektion
CO6511251A2 (es) Compuestos quimicos
DK1732604T3 (da) Fremgangsmåder til behandling af hiv-infektion
TN2010000212A1 (en) Inhibitors of human immunodeficiency virus replication
CY1110665T1 (el) Αναστολεις hiv ιντεγκρασης
ECSP109889A (es) Composiciones terapeuticas y usos de las mismas
AP2267A (en) Antiviral drugs for treatment of arenavirus infection.
ECSP11011310A (es) Análogos carba - nucleósido para tratamiento antiviral
EA200700717A1 (ru) Сульфонамиды
DK2155758T3 (da) Tetrahydrofuro[3,4-d]dioxolanforbindelser til anvendelse i behandlingen af virusinfektioner og cancer
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
WO2008127364A3 (en) Antiviral compounds and use thereof
NO20064555L (no) HIV-integraseinhibitorer.
MX2012001974A (es) Compuestos de biarilo y metodos de uso de los mismos.
ECSP11011054A (es) Péptidos antivirales terapéuticos
ATE534652T1 (de) Phosphono-pent-2-en-1-yl-nukleoside und analoga
DK2422786T3 (da) Nye lægemiddelkombinationer til behandling af luftvejssygdomme
CR11423A (es) NUEVOS INHIBIDORES DE sEH Y SU USO
WO2008118849A3 (en) Hiv-1 protease inhibitors
WO2006033709A3 (en) Novel nucleoside derivatives
CL2008002291A1 (es) Compuestos derivados del acido 4-fluor-benzoico, inhibidores de la polimerasa hcv, composicion farmaceutica, kit farmaceutico y su uso para el tratamiento de una infeccion viral por hepatitis c.
BRPI0814363A2 (pt) Produtos fármacos de interferon de liberação controlada e tratamento de infecção por hcv usando os mesmos
AR053775A1 (es) Nonadepsipeptidos acilados ii